TITAN PHARMACEUTICALS INC (TTNP) Stock Analyst Ratings
USA - NASDAQ:TTNP - US8883147055 - Common Stock
4.61 USD
-0.18 (-3.76%)
5.91 USD
+1.3 (+28.2%)
ChartMill assigns a Buy % Consensus number of 43% to TTNP. The Buy consensus is the weighted average rating of the current analysts ratings.
TTNP was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about TTNP.
In the previous month the buy percentage consensus was at a similar level.
TTNP was analyzed by 6 analysts. More opinions would make the average more meaningful.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2022-05-26 | Maxim Group | Downgrade | Buy -> Hold |
| 2021-02-18 | Maxim Group | Upgrade | Hold -> Buy |
TITAN PHARMACEUTICALS INC / TTNP FAQ
Can you provide the consensus rating for TITAN PHARMACEUTICALS INC stock?
The consensus rating for TITAN PHARMACEUTICALS INC (TTNP) is 43.3333 / 100 . This indicates that analysts generally have a neutral outlook on the stock.
Can you provide the analyst count for TITAN PHARMACEUTICALS INC stock?
The number of analysts covering TITAN PHARMACEUTICALS INC (TTNP) is 6.